TABLE 4.
Reverse discordance patterns found in isolates by antibiotic and study site
| Antibiotic(s) with reverse discordancea | No. (%) of isolatesb |
||||
|---|---|---|---|---|---|
| IN | MD | PH | SA | Total (by drug) | |
| RIF | 0 | 0 | 2 (4.2) | 0 | 2 (4.2) |
| FQL | 0 | 7 (14.6) | 1 (2.1) | 0 | 8 (16.7) |
| AMI | 0 | 24 (50.0) | 1 (2.1) | 0 | 25 (52.1) |
| INH | 4 (8.3) | 0 | 6 (12.5) | 0 | 10 (20.8) |
| RIF + INH | 0 | 0 | 1 (2.1) | 0 | 1 (2.1) |
| RIF + FQL | 0 | 0 | 1 (2.1) | 0 | 1 (2.1) |
| RIF + FQL + AMI + INH | 0 | 1 (2.1) | 0 | 0 | 1 (2.1) |
| Total (by study site) | 4 (8.3) | 32 (66.7) | 12 (25.0) | 0 | 48 (100.0) |
a
RIF, rifampin; FQL, fluoroquinolones; AMI, aminoglycosides; INH, isoniazid.
b
IN, India; MD, Moldova; PH, Philippines; SA, South Africa.